Literature DB >> 15823379

Forest plots and the interpretation of subgroups.

Jack Cuzick.   

Abstract

Mesh：

Year:  2005        PMID： 15823379     DOI： 10.1016/S0140-6736(05)61026-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  33 in total

1.  Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.

Authors:  Katherine C Wu; Gary Gerstenblith; Eliseo Guallar; Joseph E Marine; Darshan Dalal; Alan Cheng; Eduardo Marbán; João A C Lima; Gordon F Tomaselli; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2012-01-20       Impact factor: 7.792

Review 2.  Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.

Authors:  Zhi-Guang Chen; Li Xu; Si-Wei Zhang; Yan Huang; Rui-Huan Pan
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Using clinical trial data to tailor adjuvant treatments for individual patients.

Authors:  Meredith M Regan; Richard D Gelber
Journal:  Breast       Date:  2007-08-23       Impact factor: 4.380

4.  Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.

Authors:  Min Pan; QiongXiu Zhou; ShuBei Zheng; XiaoHan You; Duo Li; Ji Zhang; ChaoSheng Chen; FeiFei Xu; ZhanYuan Li; ZhiHong Zhou; JianNa Zhang
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 5.  How to interpret figures in reports of clinical trials.

Authors:  Stuart J Pocock; Thomas G Travison; Lisa M Wruck
Journal:  BMJ       Date:  2008-05-24

6.  Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis.

Authors:  Chenggang Wei; Jieying Tan; Li Xu; Liu Juan; Si Wei Zhang; Lu Wang; Qun Wang
Journal:  Tumour Biol       Date:  2014-10-16

7.  Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis.

Authors:  Dongzhi Cen; Li Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-06       Impact factor: 4.553

8.  In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.

Authors:  Jieying Tan; Li Xu; Wenqing Yao; Yun Wan; Shuqin Zhou; Sherman Xuegang Xin
Journal:  Tumour Biol       Date:  2014-09-27

9.  Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

Authors:  Olivia Pagani; Shari Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Stig B Holmberg; Diana Crivellari; John Collins; Jurij Lindtner; Beat Thürlimann; Martin F Fey; Elizabeth Murray; John F Forbes; Alan S Coates; Aron Goldhirsch
Journal:  Breast Cancer Res Treat       Date:  2008-10-25       Impact factor: 4.872

10.  The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.

Authors:  Srdan Verstovsek; Ruben A Mesa; Jason Gotlib; Richard S Levy; Vikas Gupta; John F DiPersio; John V Catalano; Michael Deininger; Carole Miller; Richard T Silver; Moshe Talpaz; Elliott F Winton; Jimmie H Harvey; Murat O Arcasoy; Elizabeth Hexner; Roger M Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M Kantarjian
Journal:  Br J Haematol       Date:  2013-03-11       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.